Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 71610-249

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71610-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 500 mg (71610 0249 53)

Divatoroex Sodium ER is a medication that is available as per USP standards. The rest of the text appears to be either incomplete or contains errors and cannot provide any useful information.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Divalproex Fig1)

The text describes figure 1 showing the reduction in CPS rate for Divalproex Sodium Delayed-Release Tablets compared to placebo. The figure shows 50% improvement of patients, with no change or worsening in the rest.*

FDA Label Image

Figure 2 (Divalproex Fig2)

The text is describing a figure showing the reduction in CPS rate with different doses of Divalproex Sodium Delayed-Release Tablets. There is a 50% improvement for patients taking the high dose, while no change or worsening is shown for those taking the low dose.*

FDA Label Image

Fig-3 (Divalproex Fig3)

This is a list of numerical values and the name of a medication, Divalproex Sodium Extended-Release Tablets. No further context or information is available.*

FDA Label Image

Chemical Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.